|
Bacil Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
25.74 Cr.
|
P/BV
|
44.68
|
Book Value (Rs.)
|
0.98
|
|
52 Week High/Low (Rs.)
|
63/15
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
27/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Employees Cost | 0.04 | 0.04 | 0.02 | 0.04 | 0.03 |
| Other Expenses | 0.03 | 0.03 | 0.02 | 0.03 | 0.02 |
| Total Expenses | 0.06 | 0.07 | 0.04 | 0.06 | 0.06 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.06 | -0.07 | -0.04 | -0.06 | -0.06 |
| Other Income | 0.00 | 0.56 | 0.01 | 0.02 | 0.03 |
| P/L Before Interest, Excpt. Items & Tax | -0.06 | 0.49 | -0.03 | -0.04 | -0.02 |
| P/L Before Exceptional Items & Tax | -0.06 | 0.49 | -0.03 | -0.04 | -0.02 |
| P/L Before Tax | -0.06 | 0.49 | -0.03 | -0.04 | -0.02 |
| P/L After Tax from Ordinary Activities | -0.06 | 0.48 | -0.03 | -0.04 | -0.02 |
| Net Profit/Loss For the Period | -0.06 | 0.48 | -0.03 | -0.04 | -0.02 |
| | | | | | |
| Equity Share Capital | 5.89 | 5.89 | 5.89 | 5.89 | 5.89 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.10 | 0.82 | -0.06 | -0.07 | -0.04 |
| Diluted EPS (Rs.) | -0.10 | 0.82 | -0.06 | -0.07 | -0.04 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.10 | 0.82 | -0.06 | -0.07 | -0.04 |
| Diluted EPS (Rs.) | -0.10 | 0.82 | -0.06 | -0.07 | -0.04 |
